More about
Dermatitis
News
July 11, 2024
1 min read
Save
Enrollment completed in phase 2 trial of bempikibart for atopic dermatitis treatment
Enrollment has been completed in a phase 2 clinical trial for the evaluation of bempikibart as a treatment for adults with persistent, moderate to severe atopic dermatitis, Q32 Bio announced in a press release.
News
July 09, 2024
2 min read
Save
FDA approves Zoryve for atopic dermatitis in adults, children
The FDA has approved Zoryve cream 0.15% for the treatment of mild to moderate atopic dermatitis in adult and pediatric patients aged 6 years and older, Arcutis announced in a press release.
News
July 09, 2024
1 min read
Save
FDA pens action letter in response to roflumilast cream 0.15% sNDA for atopic dermatitis
The FDA is working to finalize an action letter regarding Arcutis’ supplemental new drug application for roflumilast cream 0.15% indicated for atopic dermatitis, the company announced in a press release.
Clinical Guidance
Atopic Dermatitis
Treatment Options
Oral Systemic Therapy
Clinical Guidance
Atopic Dermatitis
Treatment Options
Phototherapy
Clinical Guidance
Atopic Dermatitis
Comorbidities
Comorbidities Associated with Atopic Dermatitis
Clinical Guidance
Atopic Dermatitis
Treatment Guidelines
Atopic Dermatitis Guidelines
Clinical Guidance
Atopic Dermatitis
Presentation and Diagnosis
Diagnosis and Evaluation
Clinical Guidance
Atopic Dermatitis
Presentation and Diagnosis
Clinical Presentation
Clinical Guidance
Atopic Dermatitis
Overview